TOI
The Oncology Institute, Inc.$5.13+0.00 (—)Prev Close$4.86·MCap$512.9M·P/E—·Vol—·Yield—
▲
Buys (12M)
12
$2.61M
▼
Sells (12M)
6
$862.7K
◆
Net Activity
Net Buyer
$1.74M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at The Oncology Institute, Inc. (TOI) has been dominated by buying, with 12 insider purchases totaling $2.61M and 6 insider sales totaling $862.7K. The most recent insider transaction was by Chernett Jorey (10 percent owner), who purchased $94.9K worth of shares on Jul 22, 2026. The Oncology Institute, Inc. operates in the Healthcare sector, within the Medical - Care Facilities industry, with a market cap of $512.9M.
TOI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Chernett Jorey | 10 percent owner | Buy | 18,000 | $5.27 | $94.9K | 10,648,858 |
| Jul 16, 2026 | Podnos Yale | officer: Chief Medical Officer | Sell | 23,452 | $6.41 | $150.3K | 259,527 |
| Jul 13, 2026 | Chernett Jorey | 10 percent owner | Buy | 15,000 | $5.85 | $87.8K | 10,630,858 |
| Jun 24, 2026 | Chernett Jorey | 10 percent owner | Buy | 18,000 | $5.02 | $90.4K | 10,615,858 |
| Jun 9, 2026 | Podnos Yale | officer: Chief Medical Officer | Sell | 23,451 | $5.38 | $126.1K | 259,527 |
| Jun 5, 2026 | Chernett Jorey | 10 percent owner | Buy | 12,000 | $4.75 | $57.0K | 10,579,858 |
| May 21, 2026 | Chernett Jorey | 10 percent owner | Buy | 38,500 | $4.07 | $156.6K | 10,567,858 |
| May 20, 2026 | Chernett Jorey | 10 percent owner | Buy | 30,000 | $4.09 | $122.7K | 10,529,358 |
| Apr 16, 2026 | Kaushal Mohit | director | Sell | 95,719 | $3.50 | $335.1K | 211,016-31% |
| Apr 13, 2026 | Chernett Jorey | 10 percent owner | Buy | 20,000 | $3.10 | $62.0K | 10,499,358 |
| Mar 30, 2026 | Chernett Jorey | 10 percent owner | Buy | 27,429 | $2.96 | $81.2K | 10,479,358 |
| Mar 27, 2026 | Chernett Jorey | 10 percent owner | Buy | 50,000 | $3.15 | $157.5K | 10,451,929 |
| Mar 25, 2026 | Chernett Jorey | 10 percent owner | Buy | 125,000 | $3.11 | $388.8K | 10,401,929 |
| Mar 23, 2026 | Chernett Jorey | 10 percent owner | Buy | 25,000 | $3.35 | $83.8K | 10,276,929 |
| Mar 17, 2026 | Chernett Jorey | 10 percent owner | Buy | 398,985 | $3.07 | $1.23M | 10,251,929 |
| Jan 5, 2026 | Carter Robert Ross | officer: Chief Financial Officer | Sell | 247 | $3.56 | $879.32 | 235,122 |
| Dec 16, 2025 | Hively Brad | Director | Sell | 13,333 | $3.77 | $50.3K | 683,721 |
| Nov 20, 2025 | Pacala Mark L | Director | Sell | 50,000 | $4.00 | $200.0K | 222,811 |
| Sep 5, 2025 | M33 Growth I L.P. | Director | Sell | 6,700,000 | $3.09 | $20.70M6.8% OS | 7,932,389-46% |
| Aug 21, 2025 | Hively Brad | Director | Sell | 20,221 | $4.06 | $82.1K | 622,980 |
| Jun 9, 2025 | M33 Growth I L.P. | Director | Sell | 750,000 | $3.05 | $2.29M0.8% OS | 13,950,557 |
| Jun 5, 2025 | Hively Brad | Director | Sell | 1,976,137 | $2.87 | $5.67M2.0% OS | 712,033-74% |
| May 22, 2025 | M33 Growth I L.P. | Director | Sell | 2,000,000 | $2.71 | $5.43M2.0% OS | 14,624,233 |
| Mar 28, 2025 | Hively Brad | Director | Buy | 9,056 | $1.04 | $9.4K | 675,809 |
| Mar 28, 2025 | Johnson Karen Marie | Director | Buy | 36,224 | $1.04 | $37.7K | 203,409 |
| Mar 28, 2025 | Podnos Yale | Chief Medical Officer | Buy | 9,056 | $1.04 | $9.4K | 79,049 |
| Mar 28, 2025 | Pacala Mark L | Director | Buy | 90,562 | $1.04 | $94.3K | 224,971+67% |
| Mar 28, 2025 | Castle Jeremy | Chief Operating Officer | Buy | 9,056 | $1.04 | $9.4K | 90,386 |
| Mar 28, 2025 | Virnich Daniel | Chief Executive Officer | Buy | 22,640 | $1.04 | $23.6K | 724,363 |
| Mar 28, 2025 | Carter Robert Ross | Chief Financial Officer | Buy | 9,056 | $1.04 | $9.4K | 39,407+30% |
| Mar 28, 2025 | BARASCH RICHARD A | Director | Buy | 1,358,448 | $1.04 | $1.42M1.4% OS | 1,775,641+326% |
| Dec 2, 2024 | Hively Brad | Director | Buy | 300,000 | $0.17 | $50.0K | 666,753+82% |
| Jan 30, 2024 | Havencrest Healthcare Partners, L.P. | Sell | 8,637 | $2.12 | $18.3K | 0Exit | |
| Jan 26, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,776 | $2.21 | $96.8K | 27,498-61% |
| Jan 23, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 27,587 | $2.12 | $58.6K | 68,014-29% |
| Dec 18, 2023 | Shah Mihir | Chief Financial Officer | Buy | 100,000 | $1.27 | $127.0K | 328,122+44% |
| Nov 21, 2023 | Hively Brad | Director | Sell | 25,000 | $2.24 | $56.0K | 697,065 |
| Nov 15, 2023 | Hively Brad | Director | Sell | 47,000 | $2.52 | $118.6K | 724,182 |
| Mar 21, 2023 | BARASCH RICHARD A | Director | Buy | 30,000 | $0.55 | $16.5K | 237,193 |
| Dec 20, 2022 | Miller Matthew P | Chief Operating Officer | Buy | 73,684 | $0.95 | $70.0K | 175,325+72% |
| Nov 15, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 365,321 | $2.33 | $851.2K | 13,362,873 |
| Nov 15, 2022 | Kaushal Mohit | Director | Sell | 15,994 | $2.13 | $34.1K | 25,534-39% |
| Nov 10, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 168,281 | $3.07 | $517.3K | 13,869,475 |
| Nov 7, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 114,867 | $3.45 | $395.9K | 13,965,842 |
| Nov 2, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 150,627 | $4.26 | $640.9K | 14,120,114 |
| Oct 28, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 139,591 | $5.02 | $701.2K | 14,249,060 |
| Oct 25, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 79,800 | $5.02 | $400.7K | 14,361,360 |
| Oct 25, 2022 | Kaushal Mohit | Director | Sell | 4,798 | $4.96 | $23.8K | 41,528 |
| Oct 20, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 41,700 | $4.71 | $196.3K | 14,410,860 |
| Oct 17, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,249 | $4.63 | $200.1K | 14,441,109 |
Showing 1–50 of 55
1 / 2
TOI Insider Buying Activity
The following table shows recent insider purchases of The Oncology Institute, Inc. (TOI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Chernett Jorey | 10 percent owner | Buy | 18,000 | $5.27 | $94.9K | 10,648,858 |
| Jul 13, 2026 | Chernett Jorey | 10 percent owner | Buy | 15,000 | $5.85 | $87.8K | 10,630,858 |
| Jun 24, 2026 | Chernett Jorey | 10 percent owner | Buy | 18,000 | $5.02 | $90.4K | 10,615,858 |
| Jun 5, 2026 | Chernett Jorey | 10 percent owner | Buy | 12,000 | $4.75 | $57.0K | 10,579,858 |
| May 21, 2026 | Chernett Jorey | 10 percent owner | Buy | 38,500 | $4.07 | $156.6K | 10,567,858 |
| May 20, 2026 | Chernett Jorey | 10 percent owner | Buy | 30,000 | $4.09 | $122.7K | 10,529,358 |
| Apr 13, 2026 | Chernett Jorey | 10 percent owner | Buy | 20,000 | $3.10 | $62.0K | 10,499,358 |
| Mar 30, 2026 | Chernett Jorey | 10 percent owner | Buy | 27,429 | $2.96 | $81.2K | 10,479,358 |
| Mar 27, 2026 | Chernett Jorey | 10 percent owner | Buy | 50,000 | $3.15 | $157.5K | 10,451,929 |
| Mar 25, 2026 | Chernett Jorey | 10 percent owner | Buy | 125,000 | $3.11 | $388.8K | 10,401,929 |
| Mar 23, 2026 | Chernett Jorey | 10 percent owner | Buy | 25,000 | $3.35 | $83.8K | 10,276,929 |
| Mar 17, 2026 | Chernett Jorey | 10 percent owner | Buy | 398,985 | $3.07 | $1.23M | 10,251,929 |
| Mar 28, 2025 | Hively Brad | Director | Buy | 9,056 | $1.04 | $9.4K | 675,809 |
| Mar 28, 2025 | Johnson Karen Marie | Director | Buy | 36,224 | $1.04 | $37.7K | 203,409 |
| Mar 28, 2025 | Podnos Yale | Chief Medical Officer | Buy | 9,056 | $1.04 | $9.4K | 79,049 |
| Mar 28, 2025 | Pacala Mark L | Director | Buy | 90,562 | $1.04 | $94.3K | 224,971+67% |
| Mar 28, 2025 | Castle Jeremy | Chief Operating Officer | Buy | 9,056 | $1.04 | $9.4K | 90,386 |
| Mar 28, 2025 | Virnich Daniel | Chief Executive Officer | Buy | 22,640 | $1.04 | $23.6K | 724,363 |
| Mar 28, 2025 | Carter Robert Ross | Chief Financial Officer | Buy | 9,056 | $1.04 | $9.4K | 39,407+30% |
| Mar 28, 2025 | BARASCH RICHARD A | Director | Buy | 1,358,448 | $1.04 | $1.42M1.4% OS | 1,775,641+326% |
| Dec 2, 2024 | Hively Brad | Director | Buy | 300,000 | $0.17 | $50.0K | 666,753+82% |
| Dec 18, 2023 | Shah Mihir | Chief Financial Officer | Buy | 100,000 | $1.27 | $127.0K | 328,122+44% |
| Mar 21, 2023 | BARASCH RICHARD A | Director | Buy | 30,000 | $0.55 | $16.5K | 237,193 |
| Dec 20, 2022 | Miller Matthew P | Chief Operating Officer | Buy | 73,684 | $0.95 | $70.0K | 175,325+72% |
TOI Insider Selling Activity
The following table shows recent insider sales of The Oncology Institute, Inc. (TOI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Podnos Yale | officer: Chief Medical Officer | Sell | 23,452 | $6.41 | $150.3K | 259,527 |
| Jun 9, 2026 | Podnos Yale | officer: Chief Medical Officer | Sell | 23,451 | $5.38 | $126.1K | 259,527 |
| Apr 16, 2026 | Kaushal Mohit | director | Sell | 95,719 | $3.50 | $335.1K | 211,016-31% |
| Jan 5, 2026 | Carter Robert Ross | officer: Chief Financial Officer | Sell | 247 | $3.56 | $879.32 | 235,122 |
| Dec 16, 2025 | Hively Brad | Director | Sell | 13,333 | $3.77 | $50.3K | 683,721 |
| Nov 20, 2025 | Pacala Mark L | Director | Sell | 50,000 | $4.00 | $200.0K | 222,811 |
| Sep 5, 2025 | M33 Growth I L.P. | Director | Sell | 6,700,000 | $3.09 | $20.70M6.8% OS | 7,932,389-46% |
| Aug 21, 2025 | Hively Brad | Director | Sell | 20,221 | $4.06 | $82.1K | 622,980 |
| Jun 9, 2025 | M33 Growth I L.P. | Director | Sell | 750,000 | $3.05 | $2.29M0.8% OS | 13,950,557 |
| Jun 5, 2025 | Hively Brad | Director | Sell | 1,976,137 | $2.87 | $5.67M2.0% OS | 712,033-74% |
| May 22, 2025 | M33 Growth I L.P. | Director | Sell | 2,000,000 | $2.71 | $5.43M2.0% OS | 14,624,233 |
| Jan 30, 2024 | Havencrest Healthcare Partners, L.P. | Sell | 8,637 | $2.12 | $18.3K | 0Exit | |
| Jan 26, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,776 | $2.21 | $96.8K | 27,498-61% |
| Jan 23, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 27,587 | $2.12 | $58.6K | 68,014-29% |
| Nov 21, 2023 | Hively Brad | Director | Sell | 25,000 | $2.24 | $56.0K | 697,065 |
| Nov 15, 2023 | Hively Brad | Director | Sell | 47,000 | $2.52 | $118.6K | 724,182 |
| Nov 15, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 365,321 | $2.33 | $851.2K | 13,362,873 |
| Nov 15, 2022 | Kaushal Mohit | Director | Sell | 15,994 | $2.13 | $34.1K | 25,534-39% |
| Nov 10, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 168,281 | $3.07 | $517.3K | 13,869,475 |
| Nov 7, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 114,867 | $3.45 | $395.9K | 13,965,842 |
| Nov 2, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 150,627 | $4.26 | $640.9K | 14,120,114 |
| Oct 28, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 139,591 | $5.02 | $701.2K | 14,249,060 |
| Oct 25, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 79,800 | $5.02 | $400.7K | 14,361,360 |
| Oct 25, 2022 | Kaushal Mohit | Director | Sell | 4,798 | $4.96 | $23.8K | 41,528 |
| Oct 20, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 41,700 | $4.71 | $196.3K | 14,410,860 |
| Oct 17, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,249 | $4.63 | $200.1K | 14,441,109 |
TOI Insiders
Similar Stocks to TOI
THC
Tenet Healthcare Corporation
$260.33-1.62%
$21.23B
EHC
Encompass Health Corporation
$121.62-0.76%
$12.07B
DVA
DaVita Inc.
$190.79+0.78%
$11.66B
ENSG
The Ensign Group, Inc.
$173.87-0.54%
$10.14B
PACS
PACS Group, Inc.
$41.89-5.98%
$7.09B
HIMS
Hims & Hers Health, Inc.
$28.11-2.45%
$6.14B
LFST
LifeStance Health Group, Inc.
$13.04-2.54%
$5.03B
CON
Concentra Group Holdings Parent, Inc.
$35.67-0.39%
$4.47B